Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAID HEAL: Naproxen for Dysmenorrhea and Chronic Pelvic Pain Prevention
NCT06861920Phase 4Recruiting
- Sponsor
- Endeavor Health
- Start
- Apr 2025
- Primary completion
- Apr 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Aprol in chronic pelvic pain (CPP), sponsored by Endeavor Health. Started Apr 2025; status: recruiting.
02
Drugs
Aprol
03
Conditions
chronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT06861920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06861920.